Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Rufinamide Solution, 1.0 mg/mL in Acetonitrile:Water (9:1), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco R0231ML
Description
An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel™ in the US and Inovelon™ in the EU.Specifications
75-05-8, 106308-44-5 | |
UN 1648 3 / PGII | |
238.19 | |
1 mL |
C10H8F2N4O | |
1.0 mg/mL in acetonitrile:water (9:1) | |
Ampule | |
2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
Recommended Storage : -20°C
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation